In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant Klebsiella pneumoniae and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center Study

Lingjun Wen, Can Luo, Xinyi Chen, Tianyao Liu, Xianping Li,* Min Wang* Department of Laboratory Medicine, The Second Xiangya Hospital of Central South University, Changsha, People’s Republic of China*These authors contributed equally to this workCorrespondence: Min Wang; Xian...

Full description

Bibliographic Details
Main Authors: Wen L, Luo C, Chen X, Liu T, Li X, Wang M
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/in-vitro-activity-of-cefepimeavibactam-against-carbapenem-resistant-kl-peer-reviewed-fulltext-article-IDR
_version_ 1797685531213037568
author Wen L
Luo C
Chen X
Liu T
Li X
Wang M
author_facet Wen L
Luo C
Chen X
Liu T
Li X
Wang M
author_sort Wen L
collection DOAJ
description Lingjun Wen, Can Luo, Xinyi Chen, Tianyao Liu, Xianping Li,* Min Wang* Department of Laboratory Medicine, The Second Xiangya Hospital of Central South University, Changsha, People’s Republic of China*These authors contributed equally to this workCorrespondence: Min Wang; Xianping Li, Department of Laboratory Medicine, The Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, 410011, People’s Republic of China, Tel +86 13298697558, Email wangmin0000@csu.edu.cn; xianpingli2017@csu.edu.cnPurpose: We aimed to evaluate the in vitro antibacterial effects of combination of cefepime/avibactam against carbapenem-resistant Klebsiella pneumonia (CRKP) and explore the resistance mechanism of FEP/AVI.Patients and Methods: This study explored the in vitro antibacterial activities of ceftazidime/avibactam (CAZ/AVI) and cefepime/avibactam (FEP/AVI) against 40 and 76 CRKP clinical isolates. Proteomics and metabolomics were employed to investigate the resistance mechanisms of CRKP to FEP/AVI.Results: FEP/AVI (MIC50/MIC90 0.5/4-64/4 μg/mL, resistance rate 17.1%) showed better antibacterial activity against CRKP than CAZ/AVI (MIC50/MIC90 4/4-128/4 μg/mL, resistance rate 20%) in vitro. Bioinformatics analysis showed that the differentially expressed proteins (DEPs) were enriched in alanine, aspartate and glutamate metabolism, and ribosome. Remarkably, transcriptional and translational activity-related pathways were inhibited in FEP/AVI resistant CRKP. Overlap analysis suggested that H-NS might play an important role in resistance to FEP/AVI in CRKP. The mRNA levels of DEPs-related genes (adhE, gltB, purA, ftsI and hns) showed the same trends as DEPs in FEP/AVI susceptible and resistant strains. FEP/AVI resistant isolates demonstrated stronger biofilm formation capacity than susceptible isolates. Metabolomics results showed that disturbed metabolites were mainly lipids, and adenine was decreased in FEP/AVI resistant CRKP.Conclusion: These results indicated that H-NS, GltB and SpoT may directly or indirectly promote biofilm formation of CRKP and led to FEP/AVI resistance, but inhibited ribosomal function. Our study provides a mechanistic insight into the acquisition of resistance to FEP/AVI in Klebsiella pneumoniae.Keywords: carbapenem-resistantKlebsiella pneumoniae, bacterial resistance, proteomics, metabolomics, cefepime/avibactam, ribosome
first_indexed 2024-03-12T00:45:31Z
format Article
id doaj.art-ccd34816c0f340cc9418a347d1afcb14
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-03-12T00:45:31Z
publishDate 2023-09-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-ccd34816c0f340cc9418a347d1afcb142023-09-14T19:09:01ZengDove Medical PressInfection and Drug Resistance1178-69732023-09-01Volume 166061607786600In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant Klebsiella pneumoniae and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center StudyWen LLuo CChen XLiu TLi XWang MLingjun Wen, Can Luo, Xinyi Chen, Tianyao Liu, Xianping Li,* Min Wang* Department of Laboratory Medicine, The Second Xiangya Hospital of Central South University, Changsha, People’s Republic of China*These authors contributed equally to this workCorrespondence: Min Wang; Xianping Li, Department of Laboratory Medicine, The Second Xiangya Hospital of Central South University, 139 Renmin Middle Road, Changsha, 410011, People’s Republic of China, Tel +86 13298697558, Email wangmin0000@csu.edu.cn; xianpingli2017@csu.edu.cnPurpose: We aimed to evaluate the in vitro antibacterial effects of combination of cefepime/avibactam against carbapenem-resistant Klebsiella pneumonia (CRKP) and explore the resistance mechanism of FEP/AVI.Patients and Methods: This study explored the in vitro antibacterial activities of ceftazidime/avibactam (CAZ/AVI) and cefepime/avibactam (FEP/AVI) against 40 and 76 CRKP clinical isolates. Proteomics and metabolomics were employed to investigate the resistance mechanisms of CRKP to FEP/AVI.Results: FEP/AVI (MIC50/MIC90 0.5/4-64/4 μg/mL, resistance rate 17.1%) showed better antibacterial activity against CRKP than CAZ/AVI (MIC50/MIC90 4/4-128/4 μg/mL, resistance rate 20%) in vitro. Bioinformatics analysis showed that the differentially expressed proteins (DEPs) were enriched in alanine, aspartate and glutamate metabolism, and ribosome. Remarkably, transcriptional and translational activity-related pathways were inhibited in FEP/AVI resistant CRKP. Overlap analysis suggested that H-NS might play an important role in resistance to FEP/AVI in CRKP. The mRNA levels of DEPs-related genes (adhE, gltB, purA, ftsI and hns) showed the same trends as DEPs in FEP/AVI susceptible and resistant strains. FEP/AVI resistant isolates demonstrated stronger biofilm formation capacity than susceptible isolates. Metabolomics results showed that disturbed metabolites were mainly lipids, and adenine was decreased in FEP/AVI resistant CRKP.Conclusion: These results indicated that H-NS, GltB and SpoT may directly or indirectly promote biofilm formation of CRKP and led to FEP/AVI resistance, but inhibited ribosomal function. Our study provides a mechanistic insight into the acquisition of resistance to FEP/AVI in Klebsiella pneumoniae.Keywords: carbapenem-resistantKlebsiella pneumoniae, bacterial resistance, proteomics, metabolomics, cefepime/avibactam, ribosomehttps://www.dovepress.com/in-vitro-activity-of-cefepimeavibactam-against-carbapenem-resistant-kl-peer-reviewed-fulltext-article-IDRcarbapenem-resistant klebsiella pneumoniaebacterial resistanceproteomicsmetabolomicscefepime/avibactam;ribosome.
spellingShingle Wen L
Luo C
Chen X
Liu T
Li X
Wang M
In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant Klebsiella pneumoniae and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center Study
Infection and Drug Resistance
carbapenem-resistant klebsiella pneumoniae
bacterial resistance
proteomics
metabolomics
cefepime/avibactam;ribosome.
title In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant Klebsiella pneumoniae and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center Study
title_full In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant Klebsiella pneumoniae and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center Study
title_fullStr In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant Klebsiella pneumoniae and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center Study
title_full_unstemmed In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant Klebsiella pneumoniae and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center Study
title_short In vitro Activity of Cefepime/Avibactam Against Carbapenem Resistant Klebsiella pneumoniae and Integrative Metabolomics-Proteomics Approach for Resistance Mechanism: A Single-Center Study
title_sort in vitro activity of cefepime avibactam against carbapenem resistant klebsiella pneumoniae and integrative metabolomics proteomics approach for resistance mechanism a single center study
topic carbapenem-resistant klebsiella pneumoniae
bacterial resistance
proteomics
metabolomics
cefepime/avibactam;ribosome.
url https://www.dovepress.com/in-vitro-activity-of-cefepimeavibactam-against-carbapenem-resistant-kl-peer-reviewed-fulltext-article-IDR
work_keys_str_mv AT wenl invitroactivityofcefepimeavibactamagainstcarbapenemresistantklebsiellapneumoniaeandintegrativemetabolomicsproteomicsapproachforresistancemechanismasinglecenterstudy
AT luoc invitroactivityofcefepimeavibactamagainstcarbapenemresistantklebsiellapneumoniaeandintegrativemetabolomicsproteomicsapproachforresistancemechanismasinglecenterstudy
AT chenx invitroactivityofcefepimeavibactamagainstcarbapenemresistantklebsiellapneumoniaeandintegrativemetabolomicsproteomicsapproachforresistancemechanismasinglecenterstudy
AT liut invitroactivityofcefepimeavibactamagainstcarbapenemresistantklebsiellapneumoniaeandintegrativemetabolomicsproteomicsapproachforresistancemechanismasinglecenterstudy
AT lix invitroactivityofcefepimeavibactamagainstcarbapenemresistantklebsiellapneumoniaeandintegrativemetabolomicsproteomicsapproachforresistancemechanismasinglecenterstudy
AT wangm invitroactivityofcefepimeavibactamagainstcarbapenemresistantklebsiellapneumoniaeandintegrativemetabolomicsproteomicsapproachforresistancemechanismasinglecenterstudy